Skip navigation

Achieve Excellence in Financial Planning, Forecasting, Gross-to-Net, Corporate Controllership and External Reporting

June 11-12, 2019
  • San Francisco, CA

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Eric Benson
Audit and Assurance Manager
Deloitte & Touche LLP

Carlos Campoy
Chief Financial Officer
Alder BioPharmaceuticals, Inc.

Jamie Davis
Professional Accounting Fellow, Office of the Chief Accountant
U.S. Securities & Exchange Commission

Sarah Esquivel
Associate Chief Accountant
U.S. Securities & Exchange Commission

Alan Fuhrman
Chief Financial Officer
Amplyx Pharmaceuticals

Mark Kaufmann
Chief Financial Officer
Ardelyx

Melanie Kavanagh
Managing Director
CFGI

Murray Kay
former Commercial Controller
AbbVie

Mike Makovec
Partner
Deloitte & Touche LLP

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals

Jim Quinlan
Partner
CFGI

Lindsi Scanlan
Managing Director
CFGI

Jennifer Sharpe
Executive Advisor, Revenue Analytics Collaborative
IntegriChain

Scott Sieckert
Controller
Adamas Pharmaceuticals

Laurie Stelzer
Chief Financial Officer
Halozyme

Michael VanderKlugt
Partner
Deloitte & Touche LLP

Angela VanScoy
Partner
Deloitte & Touche LLP

Robert Wells
Managing Director
CGFI

Marc Belsky
Chief Financial Officer
Kezar Life Sciences

Eric Benson
Audit and Assurance Manager
Deloitte & Touche LLP

Carlos Campoy
Chief Financial Officer
Alder BioPharmaceuticals, Inc.

Jamie Davis
Professional Accounting Fellow, Office of the Chief Accountant
U.S. Securities & Exchange Commission

Sarah Esquivel
Associate Chief Accountant
U.S. Securities & Exchange Commission

Alan Fuhrman
Chief Financial Officer
Amplyx Pharmaceuticals

Mark Kaufmann
Chief Financial Officer
Ardelyx

Melanie Kavanagh
Managing Director
CFGI

Murray Kay
former Commercial Controller
AbbVie

Mike Makovec
Partner
Deloitte & Touche LLP

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals

Jim Quinlan
Partner
CFGI

Lindsi Scanlan
Managing Director
CFGI

Jennifer Sharpe
Executive Advisor, Revenue Analytics Collaborative
IntegriChain

Scott Sieckert
Controller
Adamas Pharmaceuticals

Laurie Stelzer
Chief Financial Officer
Halozyme

Michael VanderKlugt
Partner
Deloitte & Touche LLP

Angela VanScoy
Partner
Deloitte & Touche LLP

Robert Wells
Managing Director
CGFI